Evaluation of hemodynamic parameters by transcranial Doppler in patients with leukoaraiosis;Estudio de los parámetros hemodinámicos en pacientes con leucoaraiosis mediante Doppler transcraneal

Revista de Neurologia

Volumn 37, Issue 4, 2003, Pages 301-311

  Sánchez Pérez, Rosa M ^a   Hernandez Lorido R ^b   Castano Perez ^b   Diaz Marin C ^a   Carneado Ruiz, J ^b   Molto Jorda J ^b  

^a Marina Baixa Hospital   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Aging; Cerebral hemodynamics; Leukoaraiosis; Neurosonology; Transcranial Doppler

Indexed keywords

ADULT; AGE; AGED; ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOW VELOCITY; BRAIN INFARCTION; COGNITIVE DEFECT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; HEADACHE; HEMODYNAMIC MONITORING; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PULSE WAVE; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE; VERTIGO;

EID: 0141961066     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3704.2003065     Document Type: Article

References (110)

1. Pantoni L, García JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review. Stroke 1995; 26: 1293-301.
2. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987; 44: 21-3.
3. De Reuck J, Schaumburg HH. Periventricular atherosclerotic leukoencephalopathy. Neurology 1972; 22: 1094-7.
4. Van Gijn J. White matters: small vessels and slow thinking in old age. Lancet 2000; 356: 612-3.
5. Pantoni L, García JH. Pathogenesis of leukoaraiosis. Stroke 1997; 28: 652-9.
6. Mäntylä R, Erkinjuntti T, Salonen O, Aronen HJ, Peltonen T, Pohjasvaara T, et al. Variable agreement between visual rating scales for white matter hyperintensities on MRI: comparison of 13 rating scales in a poststroke cohort. Stroke 1997; 28: 1614-23.
7. Martín R, Matías-Guiu J. SPECT en la leucoaraiosis. In Matías-Guiu J, Culebras A, Roman G, eds. Nuevos conceptos en demencia vascular. Barcelona: JR Prous; 1993. p. 65-9.
8. Isaka Y, Okamoto M, Ashida K, Imaizumi M. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke 1994; 25: 375-81.
9. Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Fukumura T, Masuda K, et al. Cerebral blood flow and vascular response to hypercapnia in hypertensive patients with leukoaraiosis. Ann Nucl Med 1996; 10: 293-8.
10. Miyazawa N, Satoh T, Hashizume K, Fukamachi A. Xenon contrast CT-CBF measurements in high-intensity foci on T2-weighted MR images in centrum semiovale of asymptomatic individuals. Stroke 1997; 28: 984-7.
11. Markus HS, Lythgoe DJ, Ostegaard L, O'Sullivan M, Williams SCR. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry 2000; 69: 48-53.
12. Fazekas F, Chawluk JB, Alavi A, Hurtig H, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol 1987; 8: 421-6.
13. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
14. Cacho J, García-García R, Arcaya J, Vicente JL, Lantada N. Una propuesta de aplicación y puntuación del test del reloj en la enfermedad de Alzheimer. Rev Neurol 1999; 28: 648-55.
15. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index [abstract]. Md State Med J 1965; 14: 61-5.
16. Brott T, Mouradin M, Uthman B. Dementia, ventricular enlargement, and hypertension associated with periventricular hypodensity by computed tomography. Ann Neurol 1986; 20: 129-30.
17. Rankin J. Cerebrovascular accidents in patients over the age of 60. II: Prognosis. Scott Med J 1957; 2: 200.
18. Hernández-Lorido R, Mañes R, Medrano V, Castaño L, Sánchez-Pérez RM, Moltó JM. Estudio de validez del dúplex y Doppler transcraneal. Correlación con la arteriografia. XV Reunión de la Sociedad Valenciana de Neurología. Alicante; 2000.
19. Ferrán-Aranaz M. SPSS para Windows. Análisis estadístico. Madrid: McGraw-Hill Interamericana; 2001.
20. Morera-Guitart J. Estudio transversal multicéntrico de la asistencia neurológica extrahospitalaria en la Comunidad Valenciana. Comisión de Análisis de Calidad de la Sociedad Valenciana de Neurología. Rev Neurol 1998; 27: 438-46,
21. Breteler MMB, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JHW, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994; 44: 1246-52.
22. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al, for the Cardiovascular Health Study Collaborative Research Group. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study. Stroke 1996; 27: 1274-82.
23. Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment and its control: the ARIC study. Stroke 1996; 27: 2262-70.
24. Dufouil C, de Kersaint-Gilly A, Besangon V, Levy C, Auffray E, Brunnereau L, et al. Longitudinal study of blood pressure and white matter hyperintensities: The EVA MRI Cohort. Neurology 2001; 56: 921-6.
25. Kertesz A, Black SE, Tokar G, Benke T, Carr T, Nicholson L. Periventricular and subcortical hyperintensities on magnetic resonance imaging: rims, caps, and unidentified bright objects. Arch Neurol 1988; 45: 404-8.
26. Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Payer F, et al. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter: a comparative study between stroke patients and normal volunteers. Arch Neurol 1992; 49: 825-7.
27. Hijdra A, Verbeeten B Jr, Verhulst JAPM. Relation of leukoaraiosis to lesion type in stroke patients. Stroke 1990; 21: 890-4.
28. Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R. White matter hyperintensities on MRI in the neurologically nondiseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995; 26: 1171-7.
29. Miyao S, Takano A, Teramoto J, Takahashi A. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke 1992; 23: 1434-8.
30. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Gardin JM, et al, for the Cardiovascular Health Study Collaborative Research Group. Magnetic resonance abnormalities and cardiovascular disease in older adults: The Cardiovascular Health Study. Stroke 1994; 25: 318-27.
31. Lindgren A, Roijer A, Rudling O, Norrving B, Larsson E-M, Eskilsson J, et al. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke: a population-based study. Stroke 1994; 25: 929-34.
32. Tarvonen-Schroder S, Kurki T, Raiha I, Sourander P. Leukoaraiosis and cause of death: a five year follow up. J Neurol Neurosurg Psychiatry 1995; 58: 586-9.
33. Liao D, Cooper L, Cai J, Toole J, Bryan N, Shahar E, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: The ARIC Study. Neuroepidemiology 1997; 16: 149-62.
34. Wiszniewska M, Devusyt G, Bogousslavsky J, Ghika J, van Melle G. What is the significance of Leukoaraiosis in patients with acute ischemic stroke. Arch Neurol 2000; 57: 967-73.
35. De Leeuw FE, de Groot JC, Oudkerk M, Kors JA, Hofman A, van Gijn J, et al. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology 2000; 54: 1795-801.
36. Bogousslavsky J, Regli F, Uske A. Leukoencephalopathy in patients with ischemic stroke. Stroke 1987; 18: 896-9.
37. Kozachuk WE, DeCarli C, Schapiro MB, Wagner EE, Rapoport SI, Horwitz B. White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors: a magnetic resonance imaging study. Arch Neurol 1990; 47: 1306-10.
38. Kobayashi S, Okada K, Yamashita K. Incidence of silent lacunar lesions in normal adults and its relation to cerebral blood flow and risk factors. Stroke 1991; 22: 1379-83.
39. Almkvist O, Wahlund LO, Andersson-Lundman G, Basun H, Backman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992; 49: 626-32.
40. Bots ML, van Swieten JC, Breteler MMB, de Jong PTVM, van Gijn J, Hofman A, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993; 341: 1232-7.
41. Fukuda H, Kitani M. Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke 1995; 26: 1593-7.
42. Streifler JY, Eliasziw M, Benavente OR, Hachinski VC, Fox AJ, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial. Lack of relationship between leukoaraiosis and carotid artery disease. Arch Neurol 1995; 52: 21-4.
43. Salgado ED, Weistein M, Furlan AJ, Modic MT, Beck GJ, Estes M, et al. Proton magnetic imaging in ischemic cerebrovascular disease. Ann Neurol 1986; 20: 502-7.
44. Hendrie HC, Farlow MR, Austrom-Guerriero M, Edwards MK, Williams MA. Foci of increased T2 signal intensity on brain MR scans of healthy elderly subjects. AJNR Am J Neuroradiol 1989; 10: 703-7.
45. Steingart A, Hachinski VC, Lau C, Fox AJ, Fox H, Lee D, et al. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol 1987; 44: 32-5.
46. Van Swieten JC, van den Hout JHW, van Ketel BA, Hijdra A, Wokke JHJ, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991; 114: 761-74.
47. Iidaka T. Brain MRI hyperintense lesions and cerebrovascular risk factors in the elderly [abstract]. Nippon Ronen Igakkai Zasshi 1993; 30: 317-24.
48. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Leukoaraiosis in stroke patients: the Copenhagen Stroke Study. Stroke 1995; 26: 588-92.
49. Van Swieten JC, Kappelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J. Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol 1992; 32: 177-83.
50. DeCarli C, Murphy DGM, Tranh M, Grady CL, Haxby JV, Gillette JA, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995; 45: 2077-84.
51. Goldstein IB, Bartzokis G, Hance DB, Shapiro D. Relationship between blood pressure and subcortical lesions in healthy elderly people. Stroke 1998; 29: 765-72.
52. Temelkova-Kurktschiev TS, Koehler C, Leonhardt W, Schaper F, Henkel E, Siegert G, et al. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care 1999; 22: 333-8.
53. Leys D, Pruvo JP, Scheltens P, Rondepierre P, Godefroy O, Leclerc X, et al. Leuko-araiosis: relationship with the types of focal lesions occurring in acute cerebrovascular disorders. Cerebrovasc Dis 1992; 2: 169-76.
54. Schmidt R. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol 1992; 32: 164-9.
55. Adachi T, Takagi M, Hoshino H, Inafuku T. Effect of extracranial carotid artery stenosis and other risk factors for stroke on periventricular hyperintensity. Stroke 1997; 28: 2174-9.
56. Mäntylä R, Aronen HJ, Saloken O, Pohjasvaara T, Korpelainen M, Peltonen T, et al. Magnetic resonance imaging white matter hyperintensities and mechanics of ischemic stroke. Stroke 1999; 30: 2053-8.
57. Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology 1999; 53: 132-9.
58. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps on chromosome 19q12 [abstract]. Nat Genet 1993; 3: 256-9.
59. Van Swieten JC, Geyskes GG, Derix MM, Peeck BM, Ramos LM, Van Latum JC, et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 1991; 30: 825-30.
60. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993; 50: 818-24.
61. Schmidt R, Fazekas F, Offenbacher H, Dusek T, Zach E, Reinhart B, et al. Neuropsychological correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology 1993; 43: 2490-4.
62. Breteler MMB, van Amerongen NM, van Swieten JC, Claus JJ, Grobbee DE, van Gijn J, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging: the Rotterdam Study. Stroke 1994; 25: 1109-15.
63. Schmidt R, Fazekas F, Koch M, Kapeller P, Augustin M, Offenbacher H, et al. Magnetic resonance imaging, cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects: a case-control study. Arch Neurol 1995; 52: 905-10.
64. Pullicino P, Benedict RHB, Capruso DX, Vella N, Withiam-Leitch S, Kwen PL. Neuroimaging criteria for vascular dementia. Arch Neurol 1996; 53: 723-8.
65. Scheltens P, Erkinjunti T, Leys D, Wahlund LO, Inzitari D, Del Ser T, et al. White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 1998; 39: 80-9.
66. De Groot JC, De Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47: 145-51.
67. Provinciali L, Minciotti P, Ceravolo G, Angeleri F, Sanguinetti CM. Transcranial Doppler sonography as a diagnostic tool in vascular dementia. Eur Neurol 1990; 30: 98-103.
68. Puls I, Hauck K, Demuth K, Horowski A, Schliesser M, Dörfler P, et al. Diagnostic impact of cerebral transit time in the identification of microangiopathy in dementia. A transcranial ultrasound study. Stroke 1999; 30: 2291-5.
69. Ries F, Horn R, Hillekamp J, Honisch C, Konig M, Solymosi L. Differentiation of multi-infarct and Alzheimer dementia by intracranial hemodynamic parameters. Stroke 1993; 24: 228-35.
70. López OL, Becker JT, Jungreis CA, Rezek D, Estol C, Boller F, et al. Computed tomography but not magnetic resonance imaging-identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol 1995; 52:659-64.
71. Tzourio C, Lévy C, Dufuil C, Touboul PJ, Ducimetière P, Alpérovitch A. Low cerebral blood velocity and risk of whitte matter hyperintensities. Ann Neurol 2001; 49: 411-4.
72. Leifer D, Buonanno FS, Richardson EP Jr. Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter. Neurology 1990; 40: 911-8.
73. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-9.
74. Chimowitz MI, Estes ML, Furlan AJ, Awad IA. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 1992; 49: 747-52.
75. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, et al. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT. Stroke 2001; 32: 1318-22.
76. Pullicino P, Ostrow P, Miller L, Snyder W, Munschauer F. Pontine ischemic rarefaction. Ann Neurol 1995; 37: 460-6.
77. Sabri O, Ringelstein EB, Hellwig D, Schneider R, Schreckenberger M, Kaiser HJ, et al. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 1999; 30: 556-66.
78. DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DG, et al. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J Neurol Neurosurg Psychiatry 1996; 60: 158-67.
79. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986; 19: 253-62.
80. Awad IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, 11: postmortem pathological correlations. Stroke 1986; 17: 1090-7.
81. Gupta SR, Naheedy MH, Young JC, Ghobrial M, Rubino FA, Hindo W. Periventricular white matter changes and dementia: clinical, neuropsychological, radiological, and pathological correlation. Arch Neurol 1988; 45: 637-41.
82. Furuta A, Ishii N, Nishihara Y, Horie A. Medullary arteries in aging and dementia. Stroke 1991; 22: 442-6.
83. Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995; 45: 883-8.
84. Baloh RW, Vinters HV. White matter lesions and disequilibrium in older people, II. Clinicopathologic correlation. Arch Neurol 1995; 52: 975-81.
85. Roman GC. From UBOs to Binswanger's Disease: Impact of magnetic resonance imaging on vascular dementia research. Stroke 1996; 27: 1269-73.
86. Bots ML, Breslau PJ, Briet E, de Bruyn AM, van Vliet HH, van den Ouweland FA, et al. Cardiovascular determinants of carotid artery disease. The Rotterdam Elderly Study. Hypertension 1992; 19: 717-20.
87. Streifler JY, Eliasziw M, Benavente OR, Hachinski VC, Fox AJ, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial. Lack of relationship between leukoaraiosis and carotid artery disease. Arch Neurol 1995; 52: 21-2.
88. Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Horner S, Berta G, et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988; 19: 1285-8.
89. De Reuck J, Crevits L, De Coster W, Sieben G, vander Eecken H. Pathogenesis of Binswanger chronic progressive subcortical encephalopathy. Neurology 1980; 30: 920-8.
90. De Leeuw F-E, de Groot JC, Oudkerk M, Witteman JCM, Hofman A, van Gijn J, et al. Aortic Atherosclerosis at Middle Age Predicts Cerebral White Matter Lesions in the Elderly. Stroke 2000; 31: 425-9.
91. Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol 1990; 11: 273-81.
92. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke 1991; 22: 609-14.
93. Yamauchi H, Fukuyama H, Nagahama Y, Shiozaki T, Nishizawa S, Konishi J, et al. Brain arteriolosclerosis and hemodynamic disturbance may induce leukoaraiosis. Neurology 1999; 53: 1833-8.
94. Leblanc R, Yamamoto YL, Tyler JL, Diksic M, Hakim A. Borderzone ischemia. Ann Neurol 1987; 22: 707-13.
95. Herholz K, Heindel W, Rackl A, Neubauer I, Steinbrich W, Pietrzyk U, et al. Regional cerebral blood flow in patients with leuko-araiosis and atherosclerotic carotid artery disease. Arch Neurol 1990; 47: 392-6.
96. Claus JJ, Breteler MM, Hasan D, Krenning EP, Bots ML, Grobbee DE, et al. Vascular risk factors, atherosclerosis, cerebral white matter lesions and cerebral perfusion in a population-based study. Eur J Nucl Med 1996; 23: 675-82.
97. Meguro K, Hatazawa J, Yamaguchi T, Itoh M, Matsuzawa T, Ono S, et al. Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging. Ann Neurol 1990; 28: 378-83.
98. Hatazawa J, Shimosegawa E, Satoh T, Toyoshima H, Okudera T. Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging. Stroke 1997; 28: 1944-7.
99. Okada K, Wu LH, Kobayashi S. Diffusion-weighted MRI in severe leukoaraiosis. Stroke 1999; 30: 478-9.
100. Jones DK, Lythgoe D, Horsfield MA, Simmons A, Williams SCR, Markus HS. Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI. Stroke 1999; 30: 393-7.
101. Isaka Y, Nagano K, Narita M, Ashida K, Imaizumi M. High signal intensity on T2-weighted magnetic resonance imaging and cerebral hemodynamic reserve in carotid occlusive disease. Stroke 1997; 28: 354-7.
102. Larsen FS, Olsen KS, Hansen BA, Paulson OB, Knudsen GM. Transcranial Doppler is valid for determination of lower limit of cerebral blood flow autoregulation. Stroke 1994; 25: 1985-8.
103. Dahl A, Russel D, Nyberg-Hansen R, Rootwelt K. Effect of nitroglycerin on cerebral circulation measured by transcranial Doppler and SPECT. Stroke 1989; 20: 1733-5.
104. Dahl A, Lindegaard K-F, Russel D, Nyberg-Hansen R, Rootwelt K, Sorteberg W, et al. A comparison of transcranial Doppler and cerebral blood flow studies to assess cerebral vasoreactivity. Stroke 1992; 23: 15-9.
105. Dahl A, Russel D, Nyberg-Hansen R, Rootwelt K, Bakke SJ. Cerebral vasoreactivity in unilateral carotid artery disease: a comparison of blood flow velocity and regional cerebral blood flow measurements. Stroke 1994; 25: 621-6.
106. Kuwert T, Hennerici M, Langen KJ, Herzog H, Kops ER, Aulich A, et al. Compensatory mechanisms in patients with asymptomatic carotid artery occlusion [abstract]. Neurol Res 1990; 12: 89-93.
107. Sitzer M, Knorr U, Seitz RJ. Cerebral hemodynamics during sensorimotor activation in humans. J Appl Physiol 1994; 77: 2804-11 [abstract].
108. Sugimori H, Ibayashi S, Fujii K, Sadoshima S, Kuwabara Y, Fujishima M. Can transcranial Doppler really detect reduced cerebral perfusion states? Stroke 1995; 26: 2053-60.
109. Bakker SLM, de Leeuw FE, de Groot JC, Hofman A, Koudstaal PJ, Breteler MMB. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 1999: 52; 578.
110. Matsushita K, Kuriyama Y, Nagatsuka K, Nakamura M, Sawada T, Omae T. Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension 1994; 23: 565-8.